These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22720109)

  • 21. Protective actions of melatonin against heart damage during chronic Chagas disease.
    Oliveira LG; Kuehn CC; dos Santos CD; Miranda MA; da Costa CM; Mendonça VJ; do Prado Júnior JC
    Acta Trop; 2013 Dec; 128(3):652-8. PubMed ID: 24055715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.
    Silverio JC; de-Oliveira-Pinto LM; da Silva AA; de Oliveira GM; Lannes-Vieira J
    Int J Exp Pathol; 2010 Feb; 91(1):72-86. PubMed ID: 19878357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
    Lo Presti MS; Rivarola HW; Bustamante JM; Fernández AR; Enders JE; Fretes R; Gea S; Paglini-Oliva PA
    Int J Antimicrob Agents; 2004 Jun; 23(6):634-6. PubMed ID: 15194137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease.
    Carrillo I; Rabelo RAN; Barbosa C; Rates M; Fuentes-Retamal S; González-Herrera F; Guzmán-Rivera D; Quintero H; Kemmerling U; Castillo C; Machado FS; Díaz-Araya G; Maya JD
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009978. PubMed ID: 34784372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
    Hernández M; Wicz S; Corral RS
    Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy.
    Vasconcelos JF; Souza BS; Lins TF; Garcia LM; Kaneto CM; Sampaio GP; de Alcântara AC; Meira CS; Macambira SG; Ribeiro-dos-Santos R; Soares MB
    FASEB J; 2013 Dec; 27(12):4691-702. PubMed ID: 23964077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapidly progressive course of Trypanosoma cruzi infection in mice heterozygous for hexamethylene bis-acetamide inducible 1 (Hexim1) gene.
    Mascareno E; Gupta R; Martello LA; Dhar-Mascareno M; Salciccioli L; Beckles D; Walsh MG; Machado FS; Tanowitz HB; Haseeb MA
    Microbes Infect; 2018 Jan; 20(1):25-36. PubMed ID: 28951318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory and anti-fibrotic effects of ganglioside therapy on the cardiac chronic form of experimental Trypanosoma cruzi infection.
    Cutrullis RA; Poklépovich TJ; Postan M; Freilij HL; Petray PB
    Int Immunopharmacol; 2011 Aug; 11(8):1024-31. PubMed ID: 21371583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trypanosoma cruzi reinfections provoke synergistic effect and cardiac beta-adrenergic receptors' dysfunction in the acute phase of experimental Chagas' disease.
    Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Ricardo F; d'Oro Gloria DL; Palma JA; Paglini-Oliva PA
    Exp Parasitol; 2003; 103(3-4):136-42. PubMed ID: 12880590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.
    Mukherjee S; Machado FS; Huang H; Oz HS; Jelicks LA; Prado CM; Koba W; Fine EJ; Zhao D; Factor SM; Collado JE; Weiss LM; Tanowitz HB; Ashton AW
    PLoS One; 2011 Feb; 6(2):e16959. PubMed ID: 21347238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy.
    Hoffman KA; Reynolds C; Bottazzi ME; Hotez P; Jones K
    J Am Heart Assoc; 2019 Nov; 8(22):e013365. PubMed ID: 31718442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.
    Gupta S; Smith C; Auclair S; Delgadillo Ade J; Garg NJ
    PLoS One; 2015; 10(6):e0130562. PubMed ID: 26075398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
    Calvet CM; Choi JY; Thomas D; Suzuki B; Hirata K; Lostracco-Johnson S; de Mesquita LB; Nogueira A; Meuser-Batista M; Silva TA; Siqueira-Neto JL; Roush WR; de Souza Pereira MC; McKerrow JH; Podust LM
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006132. PubMed ID: 29281643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease.
    Francisco AF; Jayawardhana S; Taylor MC; Lewis MD; Kelly JM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of infection in mice inoculated by the oral route with different developmental forms of Trypanosoma cruzi I and II.
    Dias GB; Gruendling AP; Araújo SM; Gomes ML; Toledo MJ
    Exp Parasitol; 2013 Nov; 135(3):511-7. PubMed ID: 23994765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypanosoma cruzi strains cause different myocarditis patterns in infected mice.
    Rodriguez HO; Guerrero NA; Fortes A; Santi-Rocca J; Gironès N; Fresno M
    Acta Trop; 2014 Nov; 139():57-66. PubMed ID: 25017312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic
    Fonseca R; Salgado RM; Borges da Silva H; do Nascimento RS; D'Império-Lima MR; Alvarez JM
    Front Immunol; 2018; 9():997. PubMed ID: 29867974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion.
    Waghabi MC; Keramidas M; Calvet CM; Meuser M; de Nazaré C Soeiro M; Mendonça-Lima L; Araújo-Jorge TC; Feige JJ; Bailly S
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2905-10. PubMed ID: 17526757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.